MEDITE Cancer Diagnostics Inc (MDIT)-医療機器分野:企業M&A・提携分析

◆英語タイトル:MEDITE Cancer Diagnostics Inc (MDIT) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8010971
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月21日
◆ページ数:29
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
MEDITE Cancer Diagnostics Inc (MEDITE), formerly CytoCore, Inc., specializes in the development, engineering, manufacturing and marketing of premium medical devices and consumables for detection, risk assessment and diagnosis of cancer and related diseases. Its major devices include ultrasonic decalcification instruments, tissue processing instruments, freezing microtome, cryostats, linear staining systems, staining systems, and cytology screening systems. The company products find application in processing tissue, cell collection ranging from processing to diagnosis. These devices and consumables are manufactured at is facility in Burgdorf, Germany. The company sells its products through a direct sale force located in Germany, Poland and the US, and also through independent distributors. The company is headquartered in Orlando, Florida, the US.

MEDITE Cancer Diagnostics Inc (MDIT) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
MEDITE Cancer Diagnostics Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
MEDITE Cancer Diagnostics Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
MEDITE Cancer Diagnostics Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
MEDITE Cancer Diagnostics Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
MEDITE Cancer Diagnostics Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
MEDITE Cancer Diagnostics Inc, Medical Equipment, Deal Details 10
Venture Financing 10
MEDITE Cancer Diagnostics Raises USD0.4 Million in Venture Financing 10
MEDITE Cancer Diagnostics Raises USD0.15 Million in Venture Financing 11
Partnerships 12
Medite To Enter Into Licensing Agreement With Unic Technologies 12
Medite Enters Into Agreement With Anatomical Pathology Company For Coverslipping Film 13
Equity Offering 14
CytoCore Completes First Tranche of Private Placement of Shares for USD1.5 Million 14
Debt Offering 15
MEDITE Cancer Diagnostics Raises USD5.4 Million in Private Placement of Convertible Promissory Notes 15
Acquisition 16
CytoCore Completes Acquisition Of Medite 16
MEDITE Cancer Diagnostics Inc – Key Competitors 17
MEDITE Cancer Diagnostics Inc – Key Employees 18
MEDITE Cancer Diagnostics Inc – Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Recent Developments 20
Financial Announcements 20
Aug 14, 2017: MEDITE Cancer Diagnostics Reports 2017 Second Quarter and First Six Month Financial Results 20
Corporate Communications 22
Nov 15, 2017: MEDITE Cancer Diagnostics Appoints Joel Kanter To Its Board As An Independent Director 22
Nov 08, 2017: MEDITE Cancer Diagnostics Reports Appointments of New Chairman of the Board and Chief Executive Officer 23
Apr 27, 2017: MEDITE Cancer Diagnostics Appoints Susan Weisman as Chief Financial Officer 24
Mar 07, 2017: MEDITE Cancer Diagnostics Appoints Eric M. Goehausen to Board of Directors 25
Product News 26
Jul 27, 2017: MEDITE Cancer Diagnostics to Launch SureCyte C1 Stain Globally at the 29th European Congress of Pathology 26
Other Significant Developments 27
May 10, 2017: MEDITE Cancer Diagnostics Announces Reorganization of Germany Operations 27
Apr 28, 2017: MEDITE Cancer Diagnostics Announces Reorganization of Germany Operations 28
Appendix 29
Methodology 29
About GlobalData 29
Contact Us 29
Disclaimer 29

List of Tables
MEDITE Cancer Diagnostics Inc, Medical Equipment, Key Facts, 2016 2
MEDITE Cancer Diagnostics Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
MEDITE Cancer Diagnostics Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
MEDITE Cancer Diagnostics Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
MEDITE Cancer Diagnostics Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
MEDITE Cancer Diagnostics Inc, Deals By Market, 2011 to YTD 2017 8
MEDITE Cancer Diagnostics Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
MEDITE Cancer Diagnostics Raises USD0.4 Million in Venture Financing 10
MEDITE Cancer Diagnostics Raises USD0.15 Million in Venture Financing 11
Medite To Enter Into Licensing Agreement With Unic Technologies 12
Medite Enters Into Agreement With Anatomical Pathology Company For Coverslipping Film 13
CytoCore Completes First Tranche of Private Placement of Shares for USD1.5 Million 14
MEDITE Cancer Diagnostics Raises USD5.4 Million in Private Placement of Convertible Promissory Notes 15
CytoCore Completes Acquisition Of Medite 16
MEDITE Cancer Diagnostics Inc, Key Competitors 17
MEDITE Cancer Diagnostics Inc, Key Employees 18
MEDITE Cancer Diagnostics Inc, Subsidiaries 19

★海外企業調査レポート[MEDITE Cancer Diagnostics Inc (MDIT)-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Baxter International Inc (BAX):企業の財務・戦略的SWOT分析
    Baxter International Inc (BAX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • DONG Energy Salg & Service AS:企業の戦略的SWOT分析
    DONG Energy Salg & Service AS - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • Proximus plc (PROX):企業の財務・戦略的SWOT分析
    Proximus plc (PROX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Ampcontrol Pty Ltd:企業の戦略・SWOT・財務情報
    Ampcontrol Pty Ltd - Strategy, SWOT and Corporate Finance Report Summary Ampcontrol Pty Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • General Mills Inc:企業の戦略・SWOT・財務情報
    General Mills Inc - Strategy, SWOT and Corporate Finance Report Summary General Mills Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Cobb Electric Membership Corporation:企業の戦略的SWOT分析
    Cobb Electric Membership Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and majo …
  • AmerisourceBergen Corp (ABC):医療機器:M&Aディール及び事業提携情報
    Summary AmerisourceBergen Corp (AmerisourceBergen) is a pharmaceutical sourcing and distribution services company. It offers a wide range of services ranging from drug distribution to manufacturer solutions including niche premium logistics services, reimbursement and pharmaceutical consulting servi …
  • Minnesota Municipal Power Agency:企業の戦略的SWOT分析
    Minnesota Municipal Power Agency - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pr …
  • Redbiotec AG:製薬・医療:M&Aディール及び事業提携情報
    Summary Redbiotec AG (Redbiotec) is a biopharmaceutical company that develops prophylactic vaccines, which target various virus associated diseases. The company produces multi component virus like particles and other protein assemblies through its rePAX coexpression technology. It is developing prod …
  • Oriental Land Co., Ltd.:企業の戦略・SWOT・財務情報
    Oriental Land Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Oriental Land Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Zoologischer Garten Berlin AG:企業の戦略・SWOT・財務情報
    Zoologischer Garten Berlin AG - Strategy, SWOT and Corporate Finance Report Summary Zoologischer Garten Berlin AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • BioMarin Pharmaceutical Inc (BMRN):医療機器:M&Aディール及び事業提携情報
    Summary BioMarin Pharmaceutical Inc (BioMarin) is a biopharmaceutical company which develops and commercializes innovative pharmaceuticals for treatment of serious diseases and medical conditions, such as Kyndrisa (drisapersen), Duchenne muscular dystrophy (DMD), phenylketonuria (PKU), achondroplasi …
  • Sandoz Inc-製薬・医療分野:企業M&A・提携分析
    Summary Sandoz Inc (Sandoz), a division of Novartis AG, is a generic pharmaceutical company that develops, manufactures and distributes and sells a range of prescription medicines and protein and biotechnology-based products known as biosimilars. The company also provides intermediary products inclu …
  • Culture Landmark Investment Limited:戦略・SWOT・企業財務分析
    Culture Landmark Investment Limited - Strategy, SWOT and Corporate Finance Report Summary Culture Landmark Investment Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • EVN AG:発電所・企業SWOT分析
    EVN AG - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (executives) …
  • MDxHealth SA (MDXH):医療機器:M&Aディール及び事業提携情報
    Summary MDxHealth SA (MDxHealth) develops and commercializes advanced epigenetic and other molecular tests for cancer assessment and the personalized treatment of patients. The company’s products portfolio includes ConfirmMDx, which detects absence or presence of prostate cancer; SelectMDx for prost …
  • Astex Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Astex Pharmaceuticals Inc (Astex Pharmaceuticals), is a novel drug discovery and development company with a focus on cancer and central nervous system (CNS) diseases. It discovers and develops small molecule treatments. The company’s lead product, Dacogen (indicated for the treatment of myel …
  • The Hub Power Co Ltd (HUBC):企業の財務・戦略的SWOT分析
    The Hub Power Co Ltd (HUBC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Mitsui E&S Holdings Co., Ltd. (7003):企業の財務・戦略的SWOT分析
    Mitsui E&S Holdings Co., Ltd. (7003) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • DeepOcean Group Holding BV:企業の戦略的SWOT分析
    DeepOcean Group Holding BV - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆